2974
A. Nikitjuka, A. Jirgensons
LETTER
Table 2 Deprotection Conditions Investigated for 5a
Entry
Reaction conditions
LC/MS result
1
2
3
4
5
6
7
8
DDQ (1.2 equiv), CH2Cl2/H2O, r.t., 12 h
AcCl, MeOH, r.t., 12 h
mixture
mixture
I2, Zn, MeOH, r.t., 12 h
mixture (14% 6a)
mixture (20% 6a)
mixture
TMSOTf (5 vol%) CH2Cl2, r.t., 12 h
FeCl3 (100 mol%), CH2Cl2, r.t., 12 h
[Pd(PPh3)4] (5 mol%), MeOH, r.t., 48 h or reflux 4 h
TBAF (2 equiv), THF, r.t., 24 h
NaOH (1 M), THF, r.t., 12 h
stable
stable
stable
(6) For selected references, see: (a) Yang, S.-M.; Lagu, B.;
Wilson, L. J. J. Org. Chem. 2007, 72, 8123. (b) Zhu, Z.;
Mazzola, R.; Sinning, L.; McKittrick, B.; Niu, X.; Lundell,
D.; Sun, J.; Orth, P.; Madison, V.; Guo, Z.; Ingram, R.;
Beyer, B. M. J. Med. Chem. 2008, 51, 725. (c) Mwakwari, S.
C.; Guerrant, W.; Patil, V.; Khan, S. I.; Tekwani, B. L.;
Gurard-Levin, Z. A.; Mrksich, M.; Oyelere, A. K. J. Med.
Chem. 2010, 53, 6100.
lowed by deprotection under acidic conditions is an
efficient method for the synthesis of hydroxamic acids. O-
2-Methylprenyl protection may also be useful for the syn-
thesis of other N-hydroxy compounds such as N-hydroxy-
amidines and N-hydroxyguanidines. This is a topic of
further investigation in our group.
(7) (a) Holms, J.; Mast, K.; Marcotte, P.; Elmore, I.; Li, J.;
Pease, L.; Glaser, K.; Morgan, D.; Michaelides, M.;
Davidsen, S. Bioorg. Med. Chem. Lett. 2001, 11, 2907.
(b) Grolla, A. A.; Podesta, V.; Chini, M. G.; Di Micco, S.;
Vallario, A.; Genazzani, A. A.; Canonico, P. L.; Bifulco, G.;
Tron, G. C.; Sorba, G.; Pirali, T. J. Med. Chem. 2009, 52,
2776.
(8) (a) Ngu, K.; Patel, D. V. J. Org. Chem. 1997, 62, 7088.
(b) Lai, M.-J.; Huang, H.-L.; Pan, S.-L.; Liu, Y.-M.; Peng,
C.-Y.; Lee, H.-Y.; Yeh, T.-K.; Huang, P.-H.; Teng, C.-M.;
Chen, C.-S.; Chuang, H.-Y.; Liou, J.-P. J. Med. Chem. 2012,
55, 3777.
Acknowledgment
Funding from European Social Fund (No. 2009/0203/1DP/
1.1.1.2.0/09/APIA/VIAA/023) is gratefully acknowledged.
Supporting Information for this article is available online at
synthetic procedures for compounds 2–10, their spectroscopic cha-
racterization as well as NMR spectra of compounds 2, 3, 5a–j, 6a–j
and 7–10.SnoIuifopg
r
t
ioSrantnugIifonp
r
o
otmart
(9) Moffat, D.; Patel, S.; Day, F.; Belfield, A.; Donald, A.;
Rowlands, M.; Wibawa, J.; Brotherton, D.; Stimson, L.;
Clark, V.; Owen, J.; Bawden, L.; Box, G.; Bone, E.;
Mortenson, P.; Hardcastle, A.; van Meurs, S.; Eccles, S.;
Raynaud, F.; Aherne, W. J. Med. Chem. 2010, 53, 8663.
(10) Mayr, H.; Foerner, W.; Schleyer, P.. v. R J. Am. Chem. Soc.
1979, 101, 6032.
References
(1) For reviews see: (a) Marmion, C. J.; Griffith, D.; Nolan, K.
B. Eur. J. Inorg. Chem. 2004, 3003. (b) Rao, B. G. Curr.
Pharm. Des. 2005, 11, 295. (c) For a recent application, see:
Di Fiore, A.; Maresca, A.; Supuran, C. T.; De Simone, G.
Chem. Commun. 2012, 48, 8838.
(11) Clennan, E. L.; Chen, X. J. Am. Chem. Soc. 1989, 111, 5787.
(12) Typical procedure for deprotection: To a solution of O-
protected hydroxamic acid 5i (33 mg, 0.13 mmol) in CH2Cl2
(2.6 mL) and triethylsilane (0.26 mL), was added TFA (0.26
mL) in one portion at r.t. The resulting mixture was stirred at
r.t. for 90 min. Solvents were evaporated and the reaction
mixture was treated several times with Et2O and evaporated.
The residue was dried in vacuo overnight to give
hydroxamic acid 6i in quantitative yield as colorless crystals.
For characterization of compound 6i, see: Usachova, N.;
Leitis, G.; Jirgensons, A.; Kalvins, I. Synth. Commun. 2010,
40, 927.
(2) For selected references, see: (a) Masaki, M.; Ohtake, J.;
Sugiyama, M.; Ohta, M. Bull. Chem. Soc. Jpn. 1965, 38,
1802. (b) Jung, M.; Brosch, G.; Kolle, D.; Scherf, H.;
Gerhauser, C.; Loidl, P. J. Med. Chem. 1999, 42, 4669.
(c) Kottirsch, G.; Feifel, R.; Neumann, U. J. Med. Chem.
2002, 45, 2289.
(3) Nikam, S. S.; Komberg, B. E.; Johnson, D. R.; Doherty, A.
M. Tetrahedron Lett. 1995, 36, 197.
(4) Barlaam, B.; Hamon, A.; Maudet, M. Tetrahedron Lett.
1998, 39, 7865.
(5) Hou, J.; Li, Z.; Fang, Q.; Feng, C.; Zhang, H.; Guo, W.;
Wang, H.; Gu, G.; Tian, Y.; Liu, P.; Liu, R.; Lin, J.; Shi, Y.-
K.; Yin, Z.; Shen, J.; Wang, P. G. J. Med. Chem. 2012, 55,
3066.
(13) Haslanger, M. F.; Karanewsky, D. S. US4604407 A1, 1986;
Chem Abstr. 105: 208613.
(14) Kukosha, T.; Trufilkina, N.; Belyakov, S.; Katkevics, M.
Synthesis 2012, 44, 2413.
Synlett 2012, 23, 2972–2974
© Georg Thieme Verlag Stuttgart · New York